Search

1H and 13C Chemical shifts for the ATWLPPR peptide.
Authors
Herve du Penhoat, C.L.M., Badache, S., Bouchemal, N.C.
Assembly
ATWLPPR heptapeptide
Entity
1. ATWLPPR heptapeptide (polymer, Thiol state: not present), 7 monomers, 839.9794 Da Detail

ATWLPPR


Formula weight
839.9794 Da
Exptl. method
solution NMR
Refine. method
simulated annealing
Data set
assigned_chemical_shifts
Chem. Shift Complete
Sequence coverage: 100.0 %, Completeness: 86.7 %, Completeness (bb): 66.7 % Detail

Polymer type: polypeptide(L)

Total1H13C
All86.7 % (72 of 83)95.7 % (45 of 47)75.0 % (27 of 36)
Backbone66.7 % (22 of 33)83.3 % (10 of 12)57.1 % (12 of 21)
Sidechain98.2 % (56 of 57)100.0 % (35 of 35)95.5 % (21 of 22)
Aromatic100.0 % (11 of 11)100.0 % (6 of 6)100.0 % (5 of 5)
Methyl100.0 % (8 of 8)100.0 % (4 of 4)100.0 % (4 of 4)

1. ATWLPPR

ATWLPPR

Sample #1

Solvent system 90% H2O/10% D2O, Pressure 1 atm, Temperature 298 K, pH 7.0, Details 10 mM phosphate buffer containing 140 mM NaCl, 5 micromolar EDTA, and 2 micromolar NaN3 at pH 7.0


#NameIsotope labelingTypeConcentration
1ATWLPPRnatural abundance6 mM
2phosphate buffernatural abundance10 mM
3NaClnatural abundance140 mM
4EDTAnatural abundance5 uM
5NaN3natural abundance2 uM
Sample #2

Solvent system 100% D2O, Pressure 1 atm, Temperature 298 K, pH 7.0, Details 10 mM phosphate buffer containing 140 mM NaCl, 5 micromolar EDTA, and 2 micromolar NaN3


#NameIsotope labelingTypeConcentration
6ATWLPPRnatural abundance6 mM
7phosphate buffernatural abundance10 mM
8NaClnatural abundance140 mM
9EDTAnatural abundance5 uM
10NaN3natural abundance2 uM

Protein Blocks Logo
Calculated from 20 models in PDB: 2JP5, Strand ID: A Detail


Release date
2008-02-19
Citation
Structure-function analysis of the antiangiogenic ATWLPPR peptide inhibiting VEGF(165) binding to neuropilin-1 and molecular dynamics simulations of the ATWLPPR/neuropilin-1 complex
Starzec, A., Vassy, R., Badache, S., Bouchemal, N.C., Herve du Penhoat, C.L.M., Perret, G.Y.
Peptides (2007), 28, 2397-2402, PubMed 17983687 , DOI 10.1016/j.peptides.2007.09.013 ,
Experiments performed 11 experiments Detail
NMR combined restraints 4 contents Detail
Keywords anti-angiogenic peptide, ATWLPPR, binding inhibitor, neuropilin-1, vascular endothelial growth factor-165